Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b
Abstract Sialic acid-binding Ig-like lectin 15 (Siglec-15) is an immune modulator and emerging cancer immunotherapy target. However, limited understanding of its structure and mechanism of action restrains the development of drug candidates that unleash its full therapeutic potential. In this study,...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-39119-8 |